Active	Status	Sponsor type	Region	Phase	Filter
2 Active 7 Inactive 9 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Reddy, Sushanth
ICC, NCT04989218: Durvalumab and Tremelimumab With Platinum-based Chemotherapy in Intrahepatic Cholangiocarcinoma	Terminated	1/2	1	US	Novel combination of chemotherapy and immunotherapy, Cisplatin (Platinol), Gemcitabine (Gemzar), Durvalumab (Imfimzi), Tremelimumab	University of Alabama at Birmingham	Cholangiocarcinoma	03/24	05/24
NCT03623984: Molecular-Guided Surgery for Pancreatic and GI Neuroendocrine Cancers	Withdrawn	1	12	US	Gallium Dotatate, Gallium-DOTATATE (68)	University of Alabama at Birmingham	Neuroendocrine Carcinoma of Pancreas, Carcinoid	06/22	06/23